PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
24-Aug-2020 Trialbee Partners with Clinerion for Expanded Access to Global Real-World Data to Accelerate Patient Recruitment for Clinical Trials Clinerion Ltd.
24-Aug-2020 MC2 Therapeutics Announces Collaboration Agreement with EPI Health on Commercialization of Newly Approved Psoriasis Drug, WYNZORA® Cream, in the US B3C newswire
24-Aug-2020 Exclusive interview with ForwardVue Pharma released for Ophthalmic Drugs 2020 SMi Group Ltd
24-Aug-2020 HAEMATO AG: Interim Report 2020 HAEMATO AG
24-Aug-2020 Targeting endothelial barrier function in critically ill COVID-19 patients: Adrecizumab shows beneficial effects Adrenomed AG
24-Aug-2020 Takeda Pharmaceutical Company Limited: Takeda to Divest its Japan Consumer Health Care Business Unit to Blackstone for JPY 242.0 Billion Takeda Pharmaceutical Company Limited
24-Aug-2020 Adlai Nortye Announces First Patient Dosed in Phase 1b Clinical Trial of AN0025 (EP4 Antagonist) in Combination with Merck's KEYTRUDA® (pembrolizumab) for Advanced Solid Tumors Adlai Nortye
24-Aug-2020 Formycon and Bioeq Enroll First Patient in Phase III Study with Aflibercept Biosimilar (FYB203) Formycon AG
24-Aug-2020 US FDA Awards Orphan Drug Designation (ODD) To Paxalisib For Malignant Glioma, Including DIPG Kazia Therapeutics Ltd
22-Aug-2020 Endo International plc Announces The Expiration And Final Tender Results Of Its Previously Announced Tender Offer Endo International plc
21-Aug-2020 PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PTC Therapeutics, Inc.
21-Aug-2020 Chesapeake Urology Named First Axonics® Center of Excellence in the U.S. Chesapeake Urology
21-Aug-2020 Exclusive video released with co-chairs of Pre-filled Syringes San Francisco Conference SMi Group Ltd
21-Aug-2020 Harbour BioMed Presented Its Newly Discovered BCMA x CD3 Bispecific Antibody at Cell Engager Summit 2020 Harbour BioMed
21-Aug-2020 Cipla and Stempeutics collaborate for launch of Stempeucel®, first 'Made in India' Cell Therapy to treat Critical Limb Ischemia (CLI) Cipla
21-Aug-2020 Dermapharm remains on growth course despite corona pandemic in the first half of 2020 Dermapharm Holding SE
21-Aug-2020 Cipla and Stempeutics collaborate for launch of Stempeucel®, first 'Made in India' Cell Therapy to treat Critical Limb Ischemia (CLI) Cipla
20-Aug-2020 FDA Approves New KYPROLIS® (carfilzomib) Combination Regimen With DARZALEX® (daratumumab) And Dexamethasone In Both Once- And Twice-Weekly Dosing Regimens Amgen
20-Aug-2020 Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Verrica Pharmaceuticals Inc. (VRCA) Glancy Prongay & Murray LLP
20-Aug-2020 Thermo Fisher Scientific and Hengrui Therapeutics, Inc. to Co-Develop Companion Diagnostic for Cancer Thermo Fisher Scientific